CRICS-TRIGGERSEP
FR|EN
Join the network

Publications

Our publications reflect our collaborations

Here is a list of the main publications resulting from research conducted within the CRICS-TRIGGERSEP network.

Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically ill patients with solid organ transplant: a retrospective multicenter study.

Vaidie J, Demiselle J, Gabriel A, Guillon A, Peju E, Pène F, et al.

Intensive Care Med. 2025 Aug;51(8):1442-1452. Epub 2025 Jul 16.

DOI : 10.1007/s00134-025-08024-7 PMID : 40668232
View publication

Management of hematological patients requiring emergency chemotherapy in the intensive care unit.

Lafarge A, Chean D, Whiting L, Clere-Jehl R; Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH); Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP).

Intensive Care Med. 2024 Jun;50(6):849-860. Epub 2024 May 15. Review.

DOI : 10.1007/s00134-024-07454-z PMID : 38748265
View publication

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.

Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, et al.

Lancet Respir Med. 2024 May;12(5):366-374. Epub 2024 Feb 1.

DOI : 10.1016/S2213-2600(23)00430-7 PMID : 38310918
View publication

Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.

Declercq PL, Fournel I, Demeyere M, Berraies A, Ksiazek E, Nyunga M, et al.

Intensive Care Med. 2023 Nov;49(11):1438-1439.

DOI : 10.1007/s00134-023-07217-2 PMID : 37755457
View publication

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al.

Lancet Respir Med. 2023 Oct;11(10):894-904. Epub 2023 May 31.

DOI : 10.1016/S2213-2600(23)00158-3 PMID : 37269870
View publication

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).

Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, et al.

Lancet Respir Med. 2023 Jul;11(7):602-612. Epub 2023 Mar 20.

DOI : 10.1016/S2213-2600(23)00092-9 PMID : 36958363
View publication

Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial.

Frat JP, Quenot JP, Badie J, Coudroy R, Guitton C, Ehrmann S, et al.

JAMA. 2022 Sep 27;328(12):1212-1222.

DOI : 10.1001/jama.2022.15613 PMID : 36166027
View publication

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.

Coudroy R, Frat JP, Ehrmann S, Pène F, Decavèle M, Terzi N, et al.

Lancet Respir Med. 2022 Jul;10(7):641-649. Epub 2022 Mar 21.

DOI : 10.1016/S2213-2600(22)00096-0 PMID : 35325620
View publication

Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: a post hoc analysis of the NUTRIREA2 trial.

Piton G, Le Gouge A, Boisramé-Helms J, Anguel N, Argaud L, Asfar P, et al.

Intensive Care Med. 2022 Apr;48(4):458-466. Epub 2022 Feb 22.

DOI : 10.1007/s00134-022-06637-w PMID : 35190840
View publication

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label metatrial.

Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, et al.

Lancet Respir Med. 2021 Dec;9(12):1387-1395. Epub 2021 Aug 20.

DOI : 10.1016/S2213-2600(21)00356-8 PMID : 34425070
View publication